Pregabalin-induced hepatotoxicity

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 7, 2011, Pages 628-

  Doǧan, Serkan ^a   Ozberk, Sümeyra ^a   Yurci, Alper ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUCOCORTICOID; PREGABALIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; JAUNDICE; LETTER; LIVER TOXICITY; PRIORITY JOURNAL; SYMPTOM;

ADULT; ANTICONVULSANTS; BILIRUBIN; DRUG-INDUCED LIVER INJURY, CHRONIC; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUCOCORTICOIDS; HUMANS; TRANSAMINASES; TREATMENT OUTCOME;

EID: 84856072611     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328346df7a     Document Type: Letter

References (5)

1. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 45 (Suppl 6):13-18. (Pubitemid 39350325)
2. Siler AC, Gardner H, Yanit K, Cushman T, McDonagh M. Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia. J Pain 2011; 12:407-415.
3. Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis 2007; 11:459-475. (Pubitemid 47302342)
4. Batt AM, Ferrari L. Manifestations of chemically induced liver damage. Clin Chem 1995; 41:1882-1887.
5. Einarsdottira S, Bjö rnsson E. Pregabalin as a probable cause of acute liver injury. Eur J Gastro Hepato 2008; 20:1049.